Bioventus Inc (BVS)
11.51
+0.10
(+0.88%)
USD |
NASDAQ |
Nov 21, 16:00
11.52
+0.01
(+0.09%)
After-Hours: 20:00
Bioventus Profit Margin (Quarterly): -3.47% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.47% |
| June 30, 2024 | -15.87% |
| March 31, 2024 | -3.53% |
| December 31, 2023 | -4.50% |
| September 30, 2023 | -6.05% |
| June 30, 2023 | -2.69% |
| March 31, 2023 | -116.9% |
| December 31, 2022 | -25.37% |
| September 30, 2022 | -84.13% |
| June 30, 2022 | -5.17% |
| March 31, 2022 | -9.61% |
| Date | Value |
|---|---|
| December 31, 2021 | -0.28% |
| September 30, 2021 | -0.98% |
| June 30, 2021 | -3.76% |
| March 31, 2021 | 30.49% |
| December 31, 2020 | 2.82% |
| September 30, 2020 | 9.84% |
| June 30, 2020 | -9.94% |
| March 31, 2020 | 13.92% |
| December 31, 2019 | 5.78% |
| March 31, 2016 | -9.25% |
| March 31, 2015 | -39.39% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-116.9%
Minimum
Mar 2023
30.49%
Maximum
Mar 2021
-11.47%
Average
-3.64%
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| Insulet Corp | 14.25% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | -17.98% |
| Catheter Precision Inc | -4.29K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -18.97% |
| Return on Assets | -4.96% |
| Return on Invested Capital | -6.61% |
| Gross Profit Margin (Quarterly) | 67.32% |
| Operating Margin (Quarterly) | 4.74% |
| Return on Net Operating Assets | -5.42% |